10x Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
10x Genomics | 8-K: 10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024
10x Genomics | 8-K: Current report
10x Genomics | 8-K: 10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
10x Genomics | 8-K: 10x Genomics Reports Third Quarter 2023 Financial Results
10x Genomics | 8-K: 10x Genomics Reports Second Quarter 2023 Financial Results
10x Genomics | 8-K: Current report
10x Genomics | 8-K: Current report
10x Genomics | 8-K: Current report
10x Genomics | 8-K: 10x Genomics Reports First Quarter 2023 Financial Results
10x Genomics | DEFA14A: Others
10x Genomics | DEF 14A: Definitive proxy statements
10x Genomics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
10x Genomics | 8-K: 10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023
10x Genomics | 8-K: 10x Genomics Reports Third Quarter 2022 Financial Results
10x Genomics | 8-K: 10x Genomics Reports Second Quarter 2022 Financial Results
10x Genomics | 8-K: Current report
10x Genomics | 8-K: Current report
10x Genomics | 8-K: Current report
10x Genomics | 8-K: 10x Genomics Reports First Quarter 2022 Financial Results Q1 2022 revenue growth of 8% over prior year
No Data